• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human GAGE5 Polyclonal Antibody

The antibody against GAGE5 was raised in rabbit using the Recombinant Human G antigen 5 protein (1-117AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, IHC.

ADC-49654A

The antibody against GAGE5 was raised in rabbit using the Recombinant Human G antigen 5 protein (1-117AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, purified by protein G with a purity greater than 95%. This antibody has been validated on ELISA, IHC.

$299.00

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADC-49654A ClonalityPolyclonal
Host SpeciesRabbitTarget NameGAGE5
Target SynonymsCancer/testis antigen 4.5 antibody; CT4.5 antibody; G antigen 5 antibody; GAGE-5 antibody; GAGE5 antibody; GAGE5_HUMAN antibodyFormLiquid
Species ReactivityHumanIsotypeIgG
Storage Buffer0.01M PBS, 0.03% Proclin 300; Constituents: 50% Glycerol, PH 7.4Purification Method>95%, Protein G purified
ConjugateNon-conjugatedApplicationELISA, IHC
StorageUpon receipt

Immunogen Information


Immunogen DescriptionRecombinant Human G antigen 5 protein (1-117AA)Target SpeciesHuman
Immunogen SequenceComplete sequences for the immunogen, target protein, and peptides are available upon request.Uniprot IDQ13069
Background Information
  • Uniprot Id

    Q13069

  • Target Species

    Human

  • Target Name

    GAGE5

  • Target Full Name

    G antigen 5

  • Target Research Area

    Cancer

  • Target Synonyms

    Cancer/testis antigen 4.5; CT4.5; G antigen 5; GAGE-5; GAGE5; GAGE5_HUMAN

Inquire Rabbit anti-Human GAGE5 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification